Marc Braunstein

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

Saad Z. Usmani, Thierry Façon, Vânia Hungria et al. · Nature Medicine · 2025 · 110 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101

Marc Braunstein, Sadeaqua Scott, Craig M. Scott et al. · Journal of Oncology · 2011 · 85 citations · Full text

Medicine, Oncology, Pharmacology +15

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)

Fernando Doñate, J. Juárez, Mark E. Burnett et al. · British Journal of Cancer · 2008 · 78 citations · Full text

Medicine, Oncology, Pharmacology +14

Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States

Jonathan I. Silverberg, Marc Braunstein, Mary Lee‐Wong · Journal of Allergy and Clinical Immunology · 2014 · 71 citations · Full text

Life Sciences, Immunology, Pediatrics +16

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum et al. · Blood Cancer Discovery · 2020 · 58 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +15